<html><head></head><body><div class="yahoo-style-wrap" style="font-family:Helvetica Neue, Helvetica, Arial, sans-serif;font-size:13px;"><div dir="ltr" data-setdir="false">Back to the start of this thread. NPR radio had a piece just this morning. <br></div><div dir="ltr" data-setdir="false"><span><br></span></div><div dir="ltr" data-setdir="false"><span>FDA has not official approved Remdesivir, but has given special permission due to Covid19.</span></div><div dir="ltr" data-setdir="false"><div dir="ltr" data-setdir="false"><div dir="ltr" data-setdir="false"><br></div><div dir="ltr" data-setdir="false">The number of doses of Remdesivir they will give free are expected to last through June. <br></div><div dir="ltr" data-setdir="false"><span><br></span></div><div><span>Giliad has not decided on the price of the drug. The discussion about possible price ranged from<br></span></div><div dir="ltr" data-setdir="false"><span>* making it inexpensive to help people.</span></div><div dir="ltr" data-setdir="false"><span>* making it expensive to encourage spending the $millions to research future drugs.<br></span></div></div><div><br></div><div dir="ltr" data-setdir="false">IMHO, those who don't like the shelter-in-place rules also would likely not want rules on drug prices.<br></div></div><div dir="ltr" data-setdir="false"><br></div><div dir="ltr" data-setdir="false"><br></div></div></body></html>